Cholinergic signaling mediates the effects of xenin-25 on secretion of pancreatic polypeptide but not insulin or glucagon in humans with impaired glucose tolerance

We previously demonstrated that infusion of an intestinal peptide called xenin-25 (Xen) amplifies the effects of glucose-dependent insulinotropic polypeptide (GIP) on insulin secretion rates (ISRs) and plasma glucagon levels in humans. However, these effects of Xen, but not GIP, were blunted in huma...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Songyan, Oestricker, Lauren Z., Wallendorf, Michael J., Sterl, Karin, Dunai, Judit, Kilpatrick, C. Rachel, Patterson, Bruce W., Reeds, Dominic N., Wice, Burton M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5821323/
https://www.ncbi.nlm.nih.gov/pubmed/29466430
http://dx.doi.org/10.1371/journal.pone.0192441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5821323/
https://www.ncbi.nlm.nih.gov/pubmed/29466430
http://dx.doi.org/10.1371/journal.pone.0192441

Ejemplares similares